These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20438589)

  • 1. Re: Intravesical prostatic protrusion (IPP) and uroflowmetry in the management of benign prostatic enlargement (BPE).
    Foo KT; Lee LS
    Int J Urol; 2010 Jun; 17(6):589. PubMed ID: 20438589
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment.
    Lee LS; Sim HG; Lim KB; Wang D; Foo KT
    Int J Urol; 2010 Jan; 17(1):69-74. PubMed ID: 19919641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Comment to Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment.
    Homma Y
    Int J Urol; 2010 Jan; 17(1):74. PubMed ID: 19919639
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of urodynamic analysis in patients with benign prostatic enlargement complicated with diabetes mellitus.
    Zhang K; Xu Z; Zhang J; Wang H; Zhang D; Shi B
    Urol Int; 2008; 81(2):149-52. PubMed ID: 18758211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrastructural studies of the detrusor in patients with benign prostatic hyperplasia].
    Loran OB; Vishnevskiĭ AE; Sekamova SM
    Urol Nefrol (Mosk); 1996; (4):27-31. PubMed ID: 8928345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of bladder function in benign prostatic hyperplasia].
    Murayama K; Katsumi T
    Hinyokika Kiyo; 1992 Oct; 38(10):1135-8. PubMed ID: 1282773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
    Nakai H; Yamanishi T; Yasuda K; Kitahara S; Suzuki T
    Neurourol Urodyn; 2004; 23(7):618-22. PubMed ID: 15382181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uroflowmetry and urodynamics.
    Kaplan SA; Te AE
    Urol Clin North Am; 1995 May; 22(2):309-20. PubMed ID: 7539177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urodynamic studies on benign prostatic hyperplasia combined with diabetes mellitus].
    Ding J; Qi L; Zu X; Shen P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 35(7):705-10. PubMed ID: 20693712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bladder instability in patients with prostatic hypertrophy. Urodynamic study].
    Aragona F; Marconi A; Spinelli C; Morelli G; Murzi P
    Ann Urol (Paris); 1987; 21(1):13-6. PubMed ID: 2436567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urodynamics of the lower urinary tract in patients with prostatic adenoma and cancer before and after transurethral surgery].
    Caravia Pubillones I; Bardo Toscano M; Alonso Rodríguez L; Reyes Arencibia R; Cruz Reyes R
    Urol Nefrol (Mosk); 1989; (1):46-8. PubMed ID: 2470187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapeutic targets to prevent benign prostatic enlargement and symptomatic progression to benign prostatic obstruction-ICI-RS 2023.
    Kanai A; Chakrabarty B; Winder M; Hashim H; Wein A; Abrams P; Fry C
    Neurourol Urodyn; 2024 Aug; 43(6):1363-1371. PubMed ID: 37916442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Nakai H, Yamanishi T, Yasuda K, Kitahara S, Suzuki T. 2004. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
    Schaefer W
    Neurourol Urodyn; 2006; 25(1):99-100. PubMed ID: 16178001
    [No Abstract]   [Full Text] [Related]  

  • 15. Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement.
    Porru D; Scarpa RM; Prezioso D; Bertaccini A; Rizzi CA;
    Prostate Cancer Prostatic Dis; 2005; 8(1):45-9. PubMed ID: 15655566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder wall tension in benign prostatic hypertrophy.
    Anikwe RM
    Invest Urol; 1977 May; 14(6):452-4. PubMed ID: 67098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of MR imaging and urodynamic findings in benign prostatic hyperplasia.
    Alam AM; Sugimura K; Okizuka H; Ishida J; Igawa M
    Radiat Med; 2000; 18(2):123-8. PubMed ID: 10888045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of simplified uroflowmetry and indices of the functional state of the urinary bladder in prostatic adenoma].
    Gol'dberg VV
    Urol Nefrol (Mosk); 1974; (2):50-4. PubMed ID: 4141148
    [No Abstract]   [Full Text] [Related]  

  • 19. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement?
    Güler C; Tüzel E; Doğantekin E; Kiziltepe G
    Urol Int; 2008; 80(2):181-5. PubMed ID: 18362490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariate analysis of lower urinary tract ageing and urinary symptoms: the role of fibrosis.
    Bercovich E; Barabino G; Pirozzi-Farina F; Deriu M
    Arch Ital Urol Androl; 1999 Dec; 71(5):287-92. PubMed ID: 10673792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.